C1 esterase inhibitor concentrate (human plasma-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C1 esterase inhibitor concentrate (human plasma-derived), covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks [Phase 3]